# Safety and Local Tolerability of Prevenar in Indian Children

> **NCT00488800** · — · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 1000 (—)

## Conditions studied

- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** pneumococcal conjugate vaccine

## Key facts

- **NCT ID:** NCT00488800
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 1000 (—)
- **Last updated:** 2007-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00488800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00488800, "Safety and Local Tolerability of Prevenar in Indian Children". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00488800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*